[Kunzang C, Parthaprasad C, Subrata S. Molecular pathways of glial tumorigenesis. Curr Sci. 2002; 82(6): 648-654.]Search in Google Scholar
[McCormick F. Signaling networks that cause cancer. Trends Cell Biol. 1999; 9(12): 53-56.10.1016/S0962-8924(99)01668-2]Search in Google Scholar
[Kitange GJ, Templeton KL, Jenkins RB. Recent advances in the molecular genetics of primary gliomas. Curr Opin Oncol. 2003; 15(3):197-203.10.1097/00001622-200305000-00003]Search in Google Scholar
[Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA. Malignant glioma: genetics and biology of a grave matter. Genes Dev. 2001; 15(11): 1311-1333.10.1101/gad.891601]Search in Google Scholar
[Nigro JM, Takahashi MA, Ginzinger DG, Law M, Passe S, Jenkins RB, Aldape K. Detection of 1p and 19q loss in oligodendroglioma by quantitative micro satellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol. 2001; 158(4): 1253-1262.10.1016/S0002-9440(10)64076-X]Search in Google Scholar
[Schmidt MC, Antweiler S, Urban N, Mueller W, Kuklik A, Meyer-Puttlitz B, Wiestler OD, Louis DN, Fimmers R, von Deimling A. Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol. 2002; 61(4): 321-328.10.1093/jnen/61.4.321]Search in Google Scholar
[Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B, Kuo WL, Gray JW, Siciliano M, Mills GB, Bast RC Jr. NOEY2 (ARHI), an imprinted putative tumor suppressor genei n ovarian and breast carcinomas. Proc Natl Acad Sci USA. 1999; 96(1): 214-219.10.1073/pnas.96.1.214]Search in Google Scholar
[Luo RZ, Peng H, Xu F, Bao J, Pang Y, Pershad R, Issa JP, Liao WS, Bast RC Jr, Yu Y. Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI. Biochimica Biophysica Acta. 2001; 1519(3): 216-222.10.1016/S0167-4781(01)00226-3]Search in Google Scholar
[Luo RZ, Fang X, Marquez R, Liu SY, Mills GB, Liao WS, Yu Y, Bast RC. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Oncogene. 2003; 22(19): 2897-2909.10.1038/sj.onc.120638012771940]Search in Google Scholar
[Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr, Yu Y. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res. 2003; 63(14): 4174-4180.]Search in Google Scholar
[Weber F, Aldred MA, Morrison CD, Plass C, Frilling A, Broelsch CE, Waite KA, Eng C. Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis. J Clin Endocrinol Metab. 2005; 90(2): 1149-1155.10.1210/jc.2004-144715546898]Search in Google Scholar
[Dalai I, Missiaglia E, Barbi S, Butturini G, Doglioni C, Falconi M, Scarpa A. Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors. Neoplasia. 2007; 9(3): 181-183.10.1593/neo.06838183857517401457]Search in Google Scholar
[Peng H, Xu F, Pershad R, Hunt KK, Frazier ML, Berchuck A, Gray JW, Hogg D, Bast RC Jr, Yu Y. ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. Int J Cancer. 2000; 86(5): 690-694.10.1002/(SICI)1097-0215(20000601)86:5<690::AID-IJC14>3.0.CO;2-K]Search in Google Scholar
[Riemenschneider MJ, Reifenberger J, Reifenberger G. Frequent biallelic inactivation and transcriptional silencing of the DIRAS3 gene at 1p31 in oligodendroglial tumors with 1p loss. Int J Cancer. 2008; 122(11): 2503-2510.10.1002/ijc.23409]Search in Google Scholar
[Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3): 1215.10.1093/nar/16.3.1215]Search in Google Scholar
[Zhenggang X, Peter WL. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 1997; 25(12): 2532-2534.10.1093/nar/25.12.2532]Search in Google Scholar
[Yu Y, Fujii S, Yuan J, Luo RZ, Wang L, Bao J, Kadota M, Oshimura M, Dent SR, Issa JP, Bast RC Jr. Epigenetic regulation of ARHI in breast and ovarian cancer cells. Ann NY Acad Sci. 2003; 983: 268-277.10.1111/j.1749-6632.2003.tb05981.x]Search in Google Scholar